Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment
靶向 CXCR4 可通过阻断细胞周期进程消除对曲妥珠单抗的耐药性,并与多西他赛在乳腺癌治疗中发挥协同作用
期刊:Breast Cancer Research
影响因子:6.1
doi:10.1186/s13058-023-01665-w
Shuying Liu, Shelly M Xie, Wenbin Liu, Mihai Gagea, Ariella B Hanker, Nguyen Nguyen, Akshara Singareeka Raghavendra, Gloria Yang-Kolodji, Fuliang Chu, Sattva S Neelapu, Adriano Marchese, Samir Hanash, Johann Zimmermann, Carlos L Arteaga, Debasish Tripathy2